Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02069379Phase 4Completed
A Phase 4 trial of metformin in insulin resistance (IR), metabolic syndrome, sponsored by University of Michigan. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02069379.